Versant Capital Management’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.3K Buy
1,427
+112
+9% +$6.05K 0.01% 1011
2026
Q1
$71.2K Buy
1,315
+1,014
+337% +$66.6K 0.01% 1040
2025
Q4
$18.5K Sell
301
-49
-14% -$3.16K ﹤0.01% 1689
2025
Q3
$25.6K Buy
350
+162
+86% +$12.8K ﹤0.01% 1450
2025
Q2
$14K Buy
188
+20
+12% +$1.4K ﹤0.01% 1720
2025
Q1
$12.6K Buy
168
+104
+163% +$9.66K ﹤0.01% 1604
2024
Q4
$6.54K Buy
64
+47
+276% +$5.39K ﹤0.01% 1625
2024
Q3
$1.79K Hold
17
﹤0.01% 1594
2024
Q2
$1.58K Buy
+17
New +$1.8K ﹤0.01% 1570

Other funds holding BXC

Versant Capital Management's BXC Position: Q2 2026 in Review

Versant Capital Management increased its BlueLinx (BXC) stake by 8.5% in Q2 2026, buying an estimated $6.05K and bringing the position to 1,427 shares worth $88.3K. The position accounts for 0.01% of the portfolio, ranked #1011.

Versant Capital Management first reported a position in BXC in Q2 2024 and has held it in 9 quarters since. 6 funds tracked by Wall St. Rank hold BXC as of Q2 2026.

  • Versant Capital Management held 1,427 shares of BlueLinx worth $88.3K as of Q2 2026.
  • Versant Capital Management bought 112 BlueLinx shares in Q2 2026, an estimated $6.05K.
  • BlueLinx made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1011 holding.
  • Versant Capital Management first reported a position in BlueLinx in Q2 2024 and has held it in 9 quarters since.
  • 6 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.